sive and minimally invasive FTC [2] . Widely invasive FTC is more aggressive and displays a poorer prognosis than minimally invasive FTC [3, 4] . Completion total thyroidectomy as a second surgery and radioactive iodine (RAI) ablation are thus recommended for invasive FTC [3] . The prognoses of patients with distant metastasis at diagnosis (M1 in the TNM classification [5] ) and/or large size (> 4 cm) is poor [5] . Minimally invasive FTC is generally an indolent disease, but some prognostic factors predicting poor disease-free survival (DFS) and poor cause-specific survival (CSS) have been identified [6] [7] [8] .
Age is one of the significant prognostic factors of minimally invasive FTC, and patients aged 45 years or older are likely to display a dire prognosis [8] . However, it is not yet known whether all FTC patients under than 45 years old will have a good prognosis, because FTC in children and adolescents is very rare. went limited thyroidectomy. Nine of these 30 patients were M1. Twenty-five of the 49 patients who underwent limited thyroidectomy at initial surgery received completion total thyroidectomy after the pathological diagnosis of widely invasive FTC. Six of these 25 patients also underwent RAI ablation.
We performed RAI therapy for all 16 of the M1 patients after total thyroidectomy. All patients were followed once or twice per year by ultrasound (US), chest roentogenography and/or computed tomography (CT) to screen for recurrence in the lymph nodes and distant organs. We repeatedly sent questionnaires to survey the patients who were postoperatively referred to other hospitals near their residences to obtain data on DFS and CSS. The average follow-up times, 127 (6-339) and 123 months (3-332 months) for minimally and widely invasive FTC, respectively, The median follow-up times for minimally and widely invasive FTC were 121 and 108 months, respectively. They were longer compared to our previous studies [6, 8] .
Twenty of the 285 M0 patients (7%) with minimally invasive FTC showed recurrence such as to lung, bone, lymph nodes and perithyroid tissue. Seven patients (2%) died of FTC; four of them were M1. Of the 70 M0 patients with widely invasive FTC, 21 (30%) showed recurrence to various organs such as lung, bone, lymph node, brain, adrenal gland, and subcutaneous tissues. Nine patients (11%) died of FTC to date; four of them were M1.
We used Fisher's' exact test to compare variables, and the Kaplan-Meier method and log rank test to analyze time-dependent variables. P-values less than 0.05 were regarded as significant, and those from 0.05 to 0.1 were regarded as marginal. We used the software program Stat View 5.0 for all analyses.
results

Outcomes of patient
Nineteen of the 285 M0 patients (7%) with minimally invasive FTC showed recurrence such as to lung (12 patients), bone (10 patients), lymph nodes (3 patients) and perithyroid tissue (1 patient). Six patients showed recurrence to two or more organs. Seven patients (2%) died of FTC; four of them were M1. Of the 70 M0 patients with widely invasive FTC, 21 (30%) showed recurrence to various organs such as lung (6 patients), bone (9 patients), lymph node (6 patients), brain (1 patient), remnant thyroid (1 patient) adrenal gland (1 patient), and Enomoto et al. analyzed 20 patients with FTC aged 20 years or younger and found that their prognoses did not significantly differ from those of older patients, but the patient series included incidentally detected FTC measuring 3 mm or smaller in surgical specimens resected due to other diseases, and the authors analyzed minimally and widely invasive FTC as a single group [9] .
In the present study, therefore, we investigated the prognostic significance of patient age by dividing FTC patients into three categories: < 20 years (children and adolescents), 20-44 years (young adults) and ≥ 45 years (middle-aged or older) and analyzed their prognoses of minimally and widely invasive FTC separately.
Patients and methods
We enrolled 292 patients with minimally invasive FTC and 79 patients with widely invasive FTC who underwent initial surgery in Kuma Hospital between 1983 and 2007 sequentially. This patient series is identical to those in two of our previous studies [6, 8] .
All hematoxylin and eosin (H&E)-stained sections were reviewed by a coauthor who is an endocrine pathologist (M.H.), and were diagnosed as minimally or widely invasive FTC based on the described criteria [6, 8] . Briefly, the definitions of capsular and vascular invasion were based on those in "Diagnostic Histopathology of Tumors, 3
rd Edition" [10] . Widely invasive FTC was diagnosed based on widespread capsular and/or vascular invasion or tumor emboli to perithyroid major blood vessels [6, 10] . Cases diagnosed as poorly differentiated carcinoma based on the WHO classification [2] and those with anaplastic components were excluded from our series. We also excluded tumors with nuclei suspected of being papillary carcinoma (follicular variant).
Seven patients with minimally invasive FTC and nine patients with widely invasive FTC had distant metastasis such as to the lung, bone, and liver at diagnosis preoperatively and were classified as M1 in the UICC TNM classification [5] .
Of the 292 minimally invasive FTC patients, 57 underwent total thyroidectomy at initial surgery. Seven of these were M1 patients and the others had pathological lesions in the contralateral lobe. The remaining 235 underwent a more limited thyroidectomy such as hemithyroidectomy and isthmectomy.
Of the 79 widely invasive FTC patients, 30 underwent total thyroidectomy and the remaining 49 under-
Age as a prognostic factor in minimally invasive FTC
Twelve, 119 and 161 of the minimally invasive FTC patients were < 20 years, aged 20-44 years and ≥ 45 years. Table 1 compares the backgrounds and clinicopathological features in the three groups. The tumor size in the patients < 20 years was larger than in those ≥ 20 years. Vascular invasion was more frequently positive in the patients < 20 years compared to those in the other two groups. Fig. 2 provides the Kaplan-Meier curves for the DFS of patients with minimally invasive FTC in the three groups. The DFS of the patients ≥ 45 years was signifisubcutaneous tissues (1 patient). Five patients showed recurrence to two or more organs. Nine patients (11%) died of FTC to date; four of them were M1.
Age classification of the patients
As indicated above, we divided the patients into three groups based on patient age: patients < 20 years old, those aged 20-44 years, and those ≥ 45 years. The numbers of minimally and widely invasive FTC among the patients < 20 years were small, at 12 and 3, respectively. Fig. 1 shows the age distribution of the minimally and widely invasive FTC patients < 20 years old. background and clinicopathological features of the 79 patients with widely invasive FTC. This number of patients is small, and only three of these patients were younger than 20 years. The DFS of the widely invasive FTC patients < 45 years tended to be poorer than that the patients ≥ 45 years (Fig. 4) , but the difference did not reach significance. There was also no significant relationship between patient age and CSS, probably because of the small number of patients enrolled (Fig. 5) . Two of the three patients < 20 years (67%) showed recurrence, but none of the three died of FTC (Figs. 4, 5) .
cantly poorer than those of the patients < 45 years. In the subset of patients < 45 years, however, the patients < 20 years showed a poorer DFS than those aged 20-44 years.
As shown in Fig. 3 , the CSS of the patients ≥ 45 years was also poorer than those of the patients < 45 years. None of the patients < 20 years died of FTC, and the CSS of the patients aged 20-44 years was better than that of the patients ≥ 45 years.
Age as a prognostic factor in widely invasive FTC
The average age of our widely invasive FTC patients was 55.4 years old (14-87 years). Table 2 shows the DFS rate of PTC patients was the best in middle-aged patients, whereas CSS had a direct relationship with patient age [14] . Therefore, the relationship between DFS and age in minimally invasive FTC might be similar to that in PTC.
Here, the CSS rate of the minimally invasive FTC patients, in contrast, decreased with increasing patient age (Fig. 3) . This is also similar to PTC. Thyroglobulindoubling time (Tg-DT), which is the strongest dynamic prognostic factor of CSS, was significantly related to patient age [13] . The DFS and CSS of minimally invasive FTC patients have a pattern similar to that seen in PTC patients regarding their relationships with patient age.
Little is known about the prognostic factors of widely invasive FTC, although we found that M1 and large tumor size had prognostic significance [6] . In the present study, we investigated the prognostic value of patient age in widely invasive FTC, but we did not observe any significant relationship between patient age and widely invasive FTC. This could be because of the small number of patients we analyzed; our series included only three patients < 20 years. Interestingly, two patients showed recurrence but neither died of FTC. This finding is similar to that in minimally invasive FTC.
In summary, we demonstrated that DFS showed a biphasic pattern and the CSS rate decreased with increasing patient age in minimally invasive FTC. In widely invasive FTC, similar to minimally invasive FTC, patients < 20 years might be likely to show recurrence but are unlikely to die of FTC. Studies of larger patient series should be conducted to elucidate the relationship between patient age and prognosis in widely invasive FTC.
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discussion
Among the patients with minimally invasive FTC, those ≥ 45 years showed a significantly poorer DFS compared to those < 45 years, a result which is consistent with our previous study [8] . In the present study, we set one more cutoff age at 20 years and compared the prognoses of three age groups. FTC patients younger than 20 years old are rare, and only one study for a large number of such patients has been published [9] . In our present series, only 12 patients belonged to this group, but there are two typical characteristics: frequent large tumor size (> 4 cm) and vascular invasion. Large tumor size was also recognized as a prognostic factor for DFS and CSS in our previous studies [3, 8] . The high incidence of large tumor size in minimally invasive FTC might reflect a high progressing activity.
The significance of vascular invasion remains controversial. In our previous study [8] , extensive vascular invasion (four or more invasive lesions in total in all available H&E sections) [10] significantly affected the patients' prognosis, but the presence of vascular invasion did not. Sugino et al. also reported that vascular invasion was not a prognostic factor [6] . However, D'Avanzo et al. and van Heerden et al. showed that minimally invasive FTC with vascular invasion is more likely to show distant metastasis and carcinoma-related death than that only with capsular invasion [11, 12] . In our previous study, the odds ratio of capsular invasion was less than 1.0 in a multivariate analysis for DFS [8] . We therefore suggest that vascular invasion has a stronger prognostic impact than capsular invasion in minimally invasive FTC.
As shown in Figure 2 , the DFS of minimally invasive FTC shows a biphasic pattern based on patient age. This may be partially because patients < 20 years had a high incidence of potentially aggressive characteristics as indicated above. Miyauchi et al. demonstrated that in PTC patients who underwent total thyroidectomy, the incidence of persistent disease was lower in patients aged 40-59 years than in those ≥ 60 years and < 40 years [13] . Our previous study also showed that the 
